Releases
BNGO
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Bionano Genomics (BNGO) stock and general news. This information may help you make smarter investment decisions.
About BNGO
Bionano Genomics, Inc. is focused on providing optical genome mapping, solutions for genome analysis. The Company provides tools and services based primarily on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. It also provides diagnostic testing services for pediatric patients suspected of neurodevelopmental disabilities. Its Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to search for diagnostics and therapeutic targets and to streamline the identification of structural changes in chromosomes. The Saphyr system is consists of an instrument, chip consumables, reagents, and a suite of data analysis tools. It also provides proprietary molecular genetic diagnostic services for individuals demonstrating clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development.